Request Sample Inquiry
Carrier Screening Market

Carrier Screening Market

Carrier Screening Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

168

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1131

Segments Covered
  • By Type By Type Expanded Carrier Screening, Targeted Disease Carrier Screening
  • By Technology By Technology DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others
  • By End User By End User Hospitals & Clinics, Reference Laboratories, Physician Offices, Others
  • By Regions By Regions North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 2.34 Billion
Revenue 2030Revenue 2030: USD 8.27 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 17.10%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Carrier Screening Market by Type by Technology by End User by Regions - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

Data Triangulation and Market Size Estimations

FAQ
Frequently Asked Question
  • The global Carrier Screening valued at USD 2.34 Billion in 2022 and is expected to reach USD 8.27 Billion in 2030 growing at a CAGR of 17.10%.

  • The prominent players in the market are Invitae (US), Eurofins Scientific (US), Fulgent Genetics (US), OPKO Health (US), Quest Diagnostics (US), Myriad Genetics (US), Sema4 (US), Thermo Fisher Scientific (US) and Illumina (US).

  • The market is project to grow at a CAGR of 17.10% between 2023 and 2030.

  • The driving factors of the Carrier Screening include

    • Recent Development in Carrier Screening is Playing Key Role in Development of Carrier Screening Market

  • North America was the leading regional segment of the Carrier Screening in 2022.